|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Cardiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA
2 Department of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA
3 Department of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA
* To whom correspondence should be addressed. E-mail: jli{at}BIDMC.harvard.edu.
There is increasing evidence that Cyclooxygenase-2 (COX-2) possess both angiogenic and cardioprotective properties. We examined the effects of hypoxic-cardiac myocytes (H9c2) on COX-2 expression in human umbilical vein endothelial cells (HUVECs) to determine the pathway involved in COX-2 regulation. The medium from hypoxic (<1% O2) cardiac myocytes (HMCM) or normoxic cardiac myocytes (21% O2) was added to HUVEC cultures. The HMCM induced a transient increase of COX-2 mRNA expression at 1 and 3 hours, without affecting COX-1 mRNA level. A similar effect also observed in HMCM from cultured primary cardiac myocytes (Rat neonatal cardiac myocytes, RNCM). The increased COX-2 mRNA was associated with a time-dependent increase in COX-2 protein expression. COX-2 was significantly induced by VEGF (4.86±1.03 fold) and IL-1
(3.93±0.89 fold), slightly increased by TNF-
, but not by FGF2, IGF-1 or PDGFs. Analysis of proteins secreted in HMCM showed the increased levels of VEGF but not IL-1
or TNF-
. The HMCM induced COX-2 expression was inhibited by the addition of an anti-VEGF neutralizing antibody. VEGF induced endothelial cell COX-2 expression by both increasing COX-2 transcription and by prolonging COX-2 mRNA half-life. Furthermore, staurosporine, a non-selective PKC inhibitor, prevented the induction of VEGF by hypoxia. Both selective PKC
,
1 inhibitor and iNOS inhibitor decreased the induction of COX-2 by HMCM and VEGF. Finally, HMCM-induced upregulation of COX-2 was accompanied by upregulation of PGI2 and PGE2. These results suggest that VEGF is one of the principal factors produced by the hypoxic myocytes that is responsible for the induction of endothelial cell COX-2 expression. This process likely involves both PKC and NOS pathways. Our findings have important implications regarding the cardiac protection of COX-2 in ischemic heart disease
This article has been cited by other articles:
![]() |
X. An, Y. Jin, H. Guo, S.-Y. Foo, B. L. Cully, J. Wu, H. Zeng, A. Rosenzweig, and J. Li Response Gene to Complement 32, a Novel Hypoxia-Regulated Angiogenic Inhibitor Circulation, August 18, 2009; 120(7): 617 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sahin, E. Sahin, and S. Gumuslu Cyclooxygenase-2 in Cancer and Angiogenesis Angiology, April 1, 2009; 60(2): 242 - 253. [Abstract] [PDF] |
||||
![]() |
P. Voisine, A. Rosinberg, J. J. Wykrzykowska, Y. Shamis, G. F. Wu, E. Appelbaum, J. Li, F. W. Sellke, D. Pinto, C. M. Gibson, et al. Skin-derived microorgan autotransplantation as a novel approach for therapeutic angiogenesis Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H213 - H219. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Geng, Y. Cui, J. Zhao, F. Yu, Y. Zhu, G. Xu, Z. Zhang, C. Tang, and J. Du Hydrogen sulfide downregulates the aortic L-arginine/nitric oxide pathway in rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1608 - R1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Boosani, A. P. Mannam, D. Cosgrove, R. Silva, K. M. Hodivala-Dilke, V. G. Keshamouni, and A. Sudhakar Regulation of COX-2 mediated signaling by {alpha}3 type IV noncollagenous domain in tumor angiogenesis Blood, August 15, 2007; 110(4): 1168 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rydkina, A. Sahni, R. B. Baggs, D. J. Silverman, and S. K. Sahni Infection of Human Endothelial Cells with Spotted Fever Group Rickettsiae Stimulates Cyclooxygenase 2 Expression and Release of Vasoactive Prostaglandins Infect. Immun., September 1, 2006; 74(9): 5067 - 5074. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wu, J. Luo, J. S. Rana, R. Laham, F. W. Sellke, and J. Li Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells Cardiovasc Res, February 1, 2006; 69(2): 512 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Kuldo, J. Westra, S. A. Asgeirsdottir, R. J. Kok, K. Oosterhuis, M. G. Rots, J. P. Schouten, P. C. Limburg, and G. Molema Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1229 - C1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ferrario, A. M. Fisher, N. Rucker, and C. J. Gomer Celecoxib and NS-398 Enhance Photodynamic Therapy by Increasing In vitro Apoptosis and Decreasing In vivo Inflammatory and Angiogenic Factors Cancer Res., October 15, 2005; 65(20): 9473 - 9478. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Sasso, D. Torella, O. Carbonara, G. M. Ellison, M. Torella, M. Scardone, C. Marra, R. Nasti, R. Marfella, D. Cozzolino, et al. Increased Vascular Endothelial Growth Factor Expression But Impaired Vascular Endothelial Growth Factor Receptor Signaling in the Myocardium of Type 2 Diabetic Patients With Chronic Coronary Heart Disease J. Am. Coll. Cardiol., September 6, 2005; 46(5): 827 - 834. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Christensen, M. Kochukov, T. A. McNearney, G. Taglialatela, and K. N. Westlund Proton-sensing G protein-coupled receptor mobilizes calcium in human synovial cells Am J Physiol Cell Physiol, September 1, 2005; 289(3): C601 - C608. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Thompson, K. Aguan, and H. Zhou Chronic Hypoxia Inhibits Contraction of Fetal Arteries by Increased Endothelium-Derived Nitric Oxide and Prostaglandin Synthesis Reproductive Sciences, December 1, 2004; 11(8): 511 - 520. [Abstract] [PDF] |
||||
![]() |
J. Chung, S. Yoon, K. Datta, R. E. Bachelder, and A. M. Mercurio Hypoxia-Induced Vascular Endothelial Growth Factor Transcription and Protection from Apoptosis Are Dependent on {alpha}6{beta}1 Integrin in Breast Carcinoma Cells Cancer Res., July 15, 2004; 64(14): 4711 - 4716. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |